TC BioPharm (Holdings) plc (TCBP)

NASDAQ: TCBP · Delayed Price · USD
0.955
0.002 (0.21%)
At close: May 17, 2022 3:51 PM
0.950
-0.005 (-0.524%)
After-hours:May 17, 2022 4:00 PM EDT
Market Cap26.80M
Revenue (ttm)2.73M
Net Income (ttm)-5.17M
Shares Out28.06M
EPS (ttm)-0.18
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume176,367
Open0.990
Previous Close0.953
Day's Range0.901 - 1.040
52-Week Range0.880 - 3.500
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About TCBP

TCB is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled TCB to develop a range of clinical-stage cell therapies designed to combat identified cancers and viral infections. TCB is embarking on phase II-into-pivotal (phase III) clinical studies, which are expected to commence in the fourth quarter of 2021, following United Kingdom and European Union regulati...

IndustryBiotechnology
IPO DateFeb 11, 2022
CEOBryan Kobel
Employees72
Stock ExchangeNASDAQ
Ticker SymbolTCBP
Full Company Profile

Financial Performance

In 2020, TCBP's revenue was 1.98 million, a decrease of -42.26% compared to the previous year's 3.43 million. Losses were -5.46 million, -10.05% less than in 2019.

Financial numbers in millions GBPFinancial Statements

News

TC BioPharm Invited to Present at LD Micro Conference

EDINBURGH, Scotland , May 3, 2022 /PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developing platform a...

2 weeks ago - PRNewsWire

TC BioPharm to Participate in Upcoming Conferences

EDINBURGH, Scotland , April 26, 2022 /PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developing platfor...

3 weeks ago - PRNewsWire

TC BioPharm Donates to Leukemia and Lymphoma Society in Sponsorship of World AML Day

EDINBURGH, Scotland , April 21, 2022 /PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developing platfor...

3 weeks ago - PRNewsWire

TC BioPharm Receives CryoTC® Trademark for Proprietary Cell Freezing Process

6-month shelf-life milestone achieved Successful thaw of highly activated Gamma delta cells EDINBURGH, Scotland , April 6, 2022 /PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Company"...

1 month ago - PRNewsWire

TC BioPharm Announces Initiation of Equity Analyst Coverage by EF Hutton with a "Buy" Recommendation

EDINBURGH, Scotland , March 29, 2022 /PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developing platfor...

1 month ago - PRNewsWire

TC BioPharm Receives MHRA and Research Ethics Committee Approvals to Initiate Phase 2B/3 Clinical Trials for the Trea...

Trial enrollment expected to begin during the first half of 2022 EDINBURGH, Scotland , March 23, 2022 /PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: ...

1 month ago - PRNewsWire

Why Are TC Biopharm Shares Trading Higher Today

The FDA has granted Orphan Drug designation to TC Biopharm Ltd's (NASDAQ: TCBP) lead product OmnImmune for use in Acute Myeloid Leukemia.  After reviewing the Phase 1b/2a trial results in relapsed/refra...

2 months ago - Benzinga

TC BioPharm Announces FDA Orphan Drug Status Granted for OmnImmune®

Allogeneic unmodified Gamma Delta product can be stored frozen and used as an 'off-the-shelf' cell therapy EDINBURGH, Scotland , March 17, 2022 /PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" ...

2 months ago - PRNewsWire

TC Biopharm Updates Intellectual Property Portfolio

EDINBURGH, Scotland, March 15, 2022 /PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developing platform...

2 months ago - PRNewsWire

Newly-Listed TC Biopharm Highlights Early Data From Acute Myeloid Leukemia Trial

TC Biopharm Ltd (NASDAQ: TCBP) has announced interim data from Phase 1a/2b of TCB-002, OmnImmune in relapsed/refractory Acute Myeloid Leukemia (AML).  TCB-002 is the Company's allogeneic unmodified gamm...

2 months ago - Benzinga

TC BioPharm Announces Positive Phase 1b/2a Data in Late-Stage Acute Myeloid Leukemia Patients Treated with Allogeneic...

EDINBURGH, Scotland, March 8, 2022 /PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developing platform ...

2 months ago - PRNewsWire

TC Biopharm to Host Corporate Update Call on March 8th

EDINBURGH, Scotland, March 2, 2022 /PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developing platform ...

2 months ago - PRNewsWire

TC Biopharm Announces Appointment of New Board Members

EDINBURGH, Scotland, Feb. 22, 2022 /PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developing platform ...

2 months ago - PRNewsWire

TC Biopharm Announces Closing of $17.5 Million Initial Public Offering

EDINBURGH, Scotland, Feb. 15, 2022 /PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developing platform ...

3 months ago - PRNewsWire

Top Penny Stocks to Buy Right Now? 3 to Watch in Mid-February

Here's three penny stocks that investors are watching rig The post Top Penny Stocks to Buy Right Now? 3 to Watch in Mid-February   appeared first on Penny Stocks to Buy, Picks, News and Information | Pe...

Other symbols:DIDI
3 months ago - PennyStocks

5 ‘Must Watch' Penny Stocks For February 2022

5 must watch penny stocks that you should know about in February The post 5 ‘Must Watch' Penny Stocks For February 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Other symbols:ABEVNGDSWNMNKD
3 months ago - PennyStocks

TC BioPharm Begins Trading on Nasdaq Today Under Symbol "TCBP"

EDINBURGH, Scotland, Feb. 11, 2022 /PRNewswire/ -- TC BioPharm (Holdings) plc ("TC BioPharm"), a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for canc...

3 months ago - PRNewsWire